DawMed Systems PLC
29 June 2007
For immediate release
29 June 2007
DAWMED SYSTEMS plc
Total Voting Rights
For the purposes of the Disclosure and Transparency Rules of the Financial
Services Authority, the Board of Dawmed Systems plc (the 'Company') is required
to notify the market of the following:
As at the date of this announcement, the Company's issued share capital consists
of 20,613,292 ordinary shares with a nominal value of 5p each, with voting
rights ('Ordinary Shares'). The Company does not hold any Ordinary Shares in
Treasury.
Therefore the total number of Ordinary Shares in the Company with voting rights
is 20,613,292.
The above figure of 20,613,292 Ordinary Shares may be used by shareholders in
the Company as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to their
interest in, the share capital of the Company under the Financial Service
Authority's Disclosure and Transparency Rules.
ENDS
For further information, please contact:
Dawmed Systems plc
Kevin Gilmore, Executive Chairman
Tel 01789 740010
Beaumont Cornish Limited
Roland Cornish
Tel +44 (0) 20 7628 3396
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.